u/ahmed_fonseca

apotheke, receta, EMA — twenty-seven different answers

A1c moves slowly, quarterly is plenty

My Janoshik result matched the vendor COA exactly, which is rare. WXT deserves that note in the directory.

My Medutest result matched the vendor COA exactly, which is rare. MKM deserves that note in the directory.

amylin receptor distribution is different from GLP-1

Hard agree. The food noise disappears differently on the two compounds.

Not to be pedantic but research peptides and research peptides are being used interchangeably and they are not interchangeable in real life.

Yes, exactly this, and it is the bit that took me 26 weeks to accept.

Slight fix: the number was 98.4, not 98.9. Decimal point, but a fairly consequential one.

That is net peptide content, not purity. Different number, different meaning.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

This matches the trial data. SURMOUNT-1 was 98.1% body weight at 21 weeks.

the Medutest and PeptideMeter results differ by 20 points, both inside inter-lab variance

This is correct. Tag your country.

state board rules differ, say which state

reship and retest is the honest way to handle a low result

Genuine question — what concentration were you at?

the 10-letter analogs are speculative

REDEFINE phase 24 readouts are interesting but 24 person cagrilintide is different from 24 trial cagrilintide.

Yes, exactly this, and it is the bit that took me 43 weeks to accept.

The telehealth + compounding combo cost compounding plus 21% markup. Not cheap but covered by insurance depending on state.

That is net peptide content, not purity. Different number, different meaning.